# The Effects of Physical Training, ASA (Aspirin), and Clopidogrel on the Walking Capacity of Patients With Stage II Peripheral Arterial Disease (PAD)

> **NCT00189618** · PHASE4 · COMPLETED · sponsor: **Arteriogenesis Competence Network** · enrollment: 250 (estimated)

## Conditions studied

- Peripheral Arterial Disease

## Interventions

- **DRUG:** Aspirin
- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT00189618
- **Lead sponsor:** Arteriogenesis Competence Network
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** 2008-04
- **Final completion:** 2008-06
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2008-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00189618

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00189618, "The Effects of Physical Training, ASA (Aspirin), and Clopidogrel on the Walking Capacity of Patients With Stage II Peripheral Arterial Disease (PAD)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00189618. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*